Raymond James Maintains Outperform on HCA Healthcare, Lowers Price Target to $280
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst John Ransom has maintained an 'Outperform' rating on HCA Healthcare (NYSE:HCA), but lowered the price target from $320 to $280.

October 25, 2023 | 11:45 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HCA Healthcare's price target has been lowered from $320 to $280 by Raymond James, although the 'Outperform' rating is maintained.
The lowering of the price target by Raymond James could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Outperform' rating indicates that the analyst still sees potential in the company, which could balance out the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100